Target intelligence / Profile preview

Haptoglobin-2 precursor (pre-haptoglobin-2), commonly referred to as Zonulin (Zonulin (no universal abbreviation, sometimes "pre-HP2"))

Target
Zonulin (no universal abbreviation, sometimes "pre-HP2")
Molecular classification
Other (modulator of tight junctions, non-standard family), Acute-phase protein (as haptoglobin precursor), Regulatory protein of epithelial/endothelial barrier
01

Overview

Zonulin is a protein identified as the precursor to haptoglobin-2 (pre-HP2) and recognized as the only physiological modulator of intercellular tight junctions described so far, responsible for reversible regulation of paracellular permeability in epithelial and endothelial cells. Zonulin is upregulated in response to luminal triggers (e.g., gliadin, bacteria), participates in innate immune defense, and is implicated in pathogenesis of various autoimmune, inflammatory, and neurological disorders through its role in increased tissue permeability. Therapeutic modulation of the zonulin pathway with antagonists like larazotide acetate is being investigated to restore barrier integrity and potentially limit disease progression in conditions characterized by leaky barriers. Technical challenges exist in measurement and specificity, since zonulin is a family of related proteins, and the exact physiological role is still being elucidated.

Other names
Zonulinpre-haptoglobin-2zonulin family peptides (ZFP)zonulin-related proteins (ZRP)zonula occludens toxin homolog
02

Mechanism of action

Antagonists (e.g., larazotide acetate, FZI/0) bind zonulin receptors or inhibit zonulin activity, restoring tight junction integrity and reducing pathological intestinal permeability

03

Biological functions

Regulation of intestinal epithelial barrier function (control of paracellular permeability)Modulation of intercellular tight junctionsInfluence on innate immunity at mucosal surfacesRegulation of tissue permeability in various organs, including the brain, liver, and blood vessels
04

Disease associations

Celiac diseaseType 1 diabetesType 2 diabetesInflammatory bowel diseases and colitisMultiple sclerosisNon-alcoholic fatty liver diseaseObesityAutism spectrum disordersSchizophreniaAttention deficit hyperactivity disorderMajor depressive disorderSepsisAnkylosing spondylitisEnvironmental enteric dysfunctionGestational diabetesNecrotizing enterocolitisCancer (e.g., glioma)Infection (HIV)
05

Safety considerations

Excessive zonulin inhibition may disrupt normal barrier homeostasis, potentially increasing risk for infections or impairing mucosal immune responseUnreliability of commercial zonulin assays/ELISA (technical issues and cross-reactivity with related proteins)Unknown long-term effects on immune tolerance
06

Interacting drugs

Larazotide acetate (a zonulin receptor antagonist)

1 more in the full profile.

07

Biomarkers

Serum zonulin levels (as a biomarker for gut permeability in numerous diseases)Intestinal permeability assays (e.g., transepithelial electrical resistance)

Beyond the preview

Go deeper on Haptoglobin-2 precursor (pre-haptoglobin-2), commonly referred to as Zonulin (Zonulin (no universal abbreviation, sometimes "pre-HP2")).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Haptoglobin-2 precursor (pre-haptoglobin-2), commonly referred to as Zonulin (Zonulin (no universal abbreviation, sometimes "pre-HP2")).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call